Mental illness is a health issue that millions of Americans live with daily. On a larger scale, approximately 450 million people worldwide have mental illness from all cultural, demographic, and socioeconomic classes.
However, there is some good news in the form of psychedelic-assisted psychotherapy, which many consider the first breakthrough in decades.
Many people’s knowledge of psilocybin (the primary psychoactive ingredient in psychedelic mushrooms) – is limited. They associate it with recreational drugs and with 1960s counterculture. Despite this, over the past two decades, a growing body of research has revealed that psilocybin may have significant potential in treating several mental health issues and behavioral disorders.
Based on this new research, psilocybin seems to be safe when administered in medical, controlled settings. It is beneficial in relieving symptoms of anxiety, treatment-resistant depression, obsessive-compulsive disorder, and other mental health disorders. It has also proved effective in reducing stress in terminally ill patients.
Many test results suggest that the positive effects of psilocybin may be long-lasting, and taking it intermittently is enough to reap its benefits and reduce the risk of significant side effects.
Psilocybin is currently considered a Schedule I controlled substance. However, current and future research is still necessary before drawing up a medical conclusion.
For additional information regarding mental health growing research, or to purchase lab created mushroom spores to preform further research, visit Hidden Forest Mushroom Spores.